These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2619974)

  • 21. Antidepressant effect of Ro 11-1163, a new MAO inhibitor.
    Stefanis CN; Alevizos BH; Papadimitriou GN
    Int Pharmacopsychiatry; 1982; 17(1):43-8. PubMed ID: 7045018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moclobemide for depression.
    Drug Ther Bull; 1994 Jan; 32(1):6-8. PubMed ID: 7635005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M; Nardi AE; Figueira IL; Stabl M
    Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M; Guelfi JD
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moclobemide and the reversible inhibitors of monoamine oxidase antidepressants.
    Priest RG
    Acta Psychiatr Scand Suppl; 1990; 360():39-41. PubMed ID: 2248065
    [No Abstract]   [Full Text] [Related]  

  • 26. Psychometric alterations in treatment with the MAO-A-inhibitor moclobemide.
    Classen W; Laux G
    J Neural Transm Suppl; 1990; 32():185-8. PubMed ID: 2089088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
    Casacchia M; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():43. PubMed ID: 2248067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparison of moclobemide and tranylcypromine in depression.
    Heinze G; Rossel L; Gabelic I; Galeano-Munoz J; Stabl M; Allen SR
    Pharmacopsychiatry; 1993 Nov; 26(6):240-5. PubMed ID: 8127928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between moclobemide and oral tyramine in depressed patients.
    Burgess CD; Mellsop GW
    Fundam Clin Pharmacol; 1989; 3(1):47-52. PubMed ID: 2714732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RIMA: a safe concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pharmacologic treatments on the sleep of depressed patients.
    Sharpley AL; Cowen PJ
    Biol Psychiatry; 1995 Jan; 37(2):85-98. PubMed ID: 7718684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of clomipramine infusion on sleep in depressed patients.
    Klein E; Hefez A; Lavie P
    Neuropsychobiology; 1984; 11(2):85-8. PubMed ID: 6483165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.
    Baumhackl U; Bizière K; Fischbach R; Geretsegger C; Hebenstreit G; Radmayr E; Stabl M
    Br J Psychiatry Suppl; 1989 Oct; (6):78-83. PubMed ID: 2695130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
    Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moclobemide versus tranylcypromine in the treatment of depression.
    Rossel L; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():61-2. PubMed ID: 2248075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of tardive akathisia with moclobemide, a reversible and selective monoamine-oxidase-A inhibitor. A case study.
    Ebert D; Demling J
    Pharmacopsychiatry; 1991 Nov; 24(6):229-31. PubMed ID: 1687486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome.
    White PD; Cleary KJ
    Int Clin Psychopharmacol; 1997 Jan; 12(1):47-52. PubMed ID: 9179634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1993 Jun; 28(2):105-16. PubMed ID: 8354766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression.
    Evans L; George T; O'Sullivan B; Mitchell P; Johnson G; Adena M
    Aust N Z J Psychiatry; 1992 Sep; 26(3):454-8. PubMed ID: 1417632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
    Dingemanse J; Kneer J; Fotteler B; Groen H; Peeters PA; Jonkman JH
    J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.